This inventor holds 1 USPTO granted patent. Top assignee: Bayer Aktiengesellschaft. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: José A Salas: Innovator in Spinosyn Biosynthesis
Introduction
José A Salas is a prominent inventor based in Oviedo, Spain. He has made significant contributions to the field of biotechnology, particularly in the area of spinosyn biosynthesis. His work has implications for agricultural practices and the development of new biopesticides.
Latest Patents
José A Salas holds a patent for "Nucleic acids which code for the enzyme activities of the spinosyn biosynthesis." This invention relates to nucleic acids that encode for enzyme activities involved in spinosyn biosynthesis, as well as the relevant enzymes themselves. Furthermore, the patent outlines methods for preparing spinosyn derivatives and precursors, showcasing his innovative approach to enhancing agricultural biotechnology.
Career Highlights
Salas is associated with Bayer Aktiengesellschaft, a leading global company in the life sciences sector. His role at Bayer has allowed him to work on cutting-edge research and development projects that aim to improve crop protection and sustainability.
Collaborations
Throughout his career, José A Salas has collaborated with notable colleagues, including Robert Velten and Volker Möhrle. These partnerships have fostered a collaborative environment that enhances innovation and drives advancements in their respective fields.
Conclusion
José A Salas is a key figure in the field of spinosyn biosynthesis, with a patent that highlights his innovative contributions. His work at Bayer Aktiengesellschaft and collaborations with esteemed colleagues further underscore his impact on agricultural biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
